Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting Prognosis

CDX2, a master transcriptional regulator of intestinal cell differentiation and survival, has been used as a marker to indicate colorectal lineage in adenocarcinomas of unknown origin. Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes for adenocarcinomas of unknown origin, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Wenbin, Hong, Hong, Awadallah, Amad, Zhou, Lan, Xin, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906088/
https://www.ncbi.nlm.nih.gov/pubmed/24489794
http://dx.doi.org/10.1371/journal.pone.0086853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906088/
https://www.ncbi.nlm.nih.gov/pubmed/24489794
http://dx.doi.org/10.1371/journal.pone.0086853

Ejemplares similares